Company profile: Avalon GloboCare
1.1 - Company Overview
Company description
- Provider of precision diagnostics and clinical lab services—including bloodwork, anatomic pathology, urine/drug toxicology, STAT blood and genetic testing, pharmacogenomic (PGx) testing via real-time PCR, and PCR COVID-19 testing—delivered via its Lab Services MSO. Also offers the FDA Class I KetoAir Breathalyzer for ketosis detection and the QTY protein design platform (joint IP with MIT) for water-soluble cytokine receptor variants.
Products and services
- Clinical Laboratory Services/Precision Diagnostics: Delivers clinical-grade range of clinical testing services including bloodwork, anatomic pathology, urine toxicology, and pharmacogenomics testing for comprehensive patient diagnostics
- Lab Services MSO: Supplies enterprise-scale diagnostic tests including drug testing, toxicology, and wellness testing, with capabilities like STAT blood testing and genetic testing for timely clinical insights
- Pharmacogenomic (PGx) Testing: Offers real-time PCR-based assays identifying genetic variants affecting medication metabolism, aiding in personalized medication management
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Avalon GloboCare
BioServ
HQ: United Kingdom
Website
- Description: Provider of biotechnology services specializing in upstream production and downstream processing of antibodies and other proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioServ company profile →
AMW
HQ: Germany
Website
- Description: Provider of drug delivery systems, including active ingredient/biodegradable implants and transdermal passive and microchip-controlled patches for oncology, pain therapy, and neurology. Offers biodegradable Goserelin and Leuprorelin implants for hormone-dependent tumors, plus CDMO manufacturing, inhouse innovation, joint development, and regulatory affairs services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AMW company profile →
Champions Oncology
HQ: United States
Website
- Description: Provider of advanced technology solutions and services for personalizing the development and use of oncology drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Champions Oncology company profile →
BioAffinity Technologies
HQ: United States
Website
- Description: Provider of non-invasive, early-stage cancer diagnostics, including CyPath® Lung, a sputum-based lung cancer test analyzed via flow cytometry and machine learning. Through Precision Pathology Laboratory Services, offers laboratory services and provides CyPath® Lung as a Laboratory Developed Test. Also conducts R&D to expand porphyrin-based platform technologies for targeted cancer diagnostics and therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioAffinity Technologies company profile →
Anterios
HQ: United States
Website
- Description: Provider of botulinum-based prescription products for aesthetic medicine and dermatology and nanotechnology-based delivery systems for administering drugs and cosmetics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anterios company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Avalon GloboCare
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Avalon GloboCare
2.2 - Growth funds investing in similar companies to Avalon GloboCare
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Avalon GloboCare
4.2 - Public trading comparable groups for Avalon GloboCare
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →